<!DOCTYPE  html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"/><title>rgpv syllabus - rgpv timetable Microsoft Word - B. Pharm Sem. VII Syllabus</title><meta name="author" content="AcademicsOne"/><style type="text/css"> * {margin:0; padding:0; text-indent:0; }
 h1 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 13pt; }
 h2 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 12pt; }
 .p, p { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; margin:0pt; }
 .s1 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; vertical-align: 4pt; }
 .a, a { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 li {display: block; }
 #l1 {padding-left: 0pt;counter-reset: c1 1; }
 #l1> li>*:first-child:before {counter-increment: c1; content: counter(c1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l1> li:first-child>*:first-child:before {counter-increment: c1 0;  }
 li {display: block; }
 #l2 {padding-left: 0pt;counter-reset: d1 1; }
 #l2> li>*:first-child:before {counter-increment: d1; content: counter(d1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l2> li:first-child>*:first-child:before {counter-increment: d1 0;  }
 li {display: block; }
 #l3 {padding-left: 0pt;counter-reset: e1 1; }
 #l3> li>*:first-child:before {counter-increment: e1; content: counter(e1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l3> li:first-child>*:first-child:before {counter-increment: e1 0;  }
 #l4 {padding-left: 0pt;counter-reset: e2 1; }
 #l4> li>*:first-child:before {counter-increment: e2; content: counter(e2, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l4> li:first-child>*:first-child:before {counter-increment: e2 0;  }
 li {display: block; }
 #l5 {padding-left: 0pt;counter-reset: f1 1; }
 #l5> li>*:first-child:before {counter-increment: f1; content: counter(f1, lower-latin)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 12pt; }
 #l5> li:first-child>*:first-child:before {counter-increment: f1 0;  }
 li {display: block; }
 #l6 {padding-left: 0pt;counter-reset: g1 1; }
 #l6> li>*:first-child:before {counter-increment: g1; content: counter(g1, lower-latin)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 12pt; }
 #l6> li:first-child>*:first-child:before {counter-increment: g1 0;  }
 li {display: block; }
 #l7 {padding-left: 0pt;counter-reset: h1 1; }
 #l7> li>*:first-child:before {counter-increment: h1; content: counter(h1, lower-latin)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 12pt; }
 #l7> li:first-child>*:first-child:before {counter-increment: h1 0;  }
 li {display: block; }
 #l8 {padding-left: 0pt;counter-reset: i1 1; }
 #l8> li>*:first-child:before {counter-increment: i1; content: counter(i1, lower-latin)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 12pt; }
 #l8> li:first-child>*:first-child:before {counter-increment: i1 0;  }
 li {display: block; }
 #l9 {padding-left: 0pt;counter-reset: j1 1; }
 #l9> li>*:first-child:before {counter-increment: j1; content: counter(j1, lower-latin)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 12pt; }
 #l9> li:first-child>*:first-child:before {counter-increment: j1 0;  }
 #l10 {padding-left: 0pt;counter-reset: j2 1; }
 #l10> li>*:first-child:before {counter-increment: j2; content: counter(j2, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l10> li:first-child>*:first-child:before {counter-increment: j2 0;  }
 li {display: block; }
 #l11 {padding-left: 0pt;counter-reset: k1 1; }
 #l11> li>*:first-child:before {counter-increment: k1; content: counter(k1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l11> li:first-child>*:first-child:before {counter-increment: k1 0;  }
 li {display: block; }
 #l12 {padding-left: 0pt;counter-reset: l1 1; }
 #l12> li>*:first-child:before {counter-increment: l1; content: counter(l1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l12> li:first-child>*:first-child:before {counter-increment: l1 0;  }
 li {display: block; }
 #l13 {padding-left: 0pt;counter-reset: m1 1; }
 #l13> li>*:first-child:before {counter-increment: m1; content: counter(m1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l13> li:first-child>*:first-child:before {counter-increment: m1 0;  }
 li {display: block; }
 #l14 {padding-left: 0pt;counter-reset: n1 1; }
 #l14> li>*:first-child:before {counter-increment: n1; content: counter(n1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l14> li:first-child>*:first-child:before {counter-increment: n1 0;  }
 #l15 {padding-left: 0pt;counter-reset: n2 2; }
 #l15> li>*:first-child:before {counter-increment: n2; content: counter(n2, decimal)" "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l15> li:first-child>*:first-child:before {counter-increment: n2 0;  }
 li {display: block; }
 #l16 {padding-left: 0pt;counter-reset: o1 1; }
 #l16> li>*:first-child:before {counter-increment: o1; content: counter(o1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l16> li:first-child>*:first-child:before {counter-increment: o1 0;  }
</style><!-- Basic Meta Tags -->
<meta charset="utf-8" />
<meta http-equiv="X-UA-Compatible" content="IE=edge" />
<meta name="viewport" content="width=device-width,initial-scale=1" />

<!-- Page Title and Description -->
<meta name="description" content="Download and view the latest RGPV syllabus and timetable in PDF." />
<meta name="keywords" content="download, view, RGPV, syllabus, timetable, PDF" />

<!-- Robots Meta Tag -->
<meta name="robots" content="index, follow" />
<link rel="sitemap" href="/sitemap.xml" />

<!-- Twitter Meta Tags -->
<meta name="twitter:card" content="summary_large_image" />
<meta name="twitter:title" content="RGPV Syllabus and Timetable" />
<meta name="twitter:description" content="Download and view the latest RGPV syllabus and timetable in PDF." />

<!-- Open Graph Meta Tags -->
<meta property="og:locale" content="en_IN" />
<meta property="og:type" content="website" />
<meta property="og:site_name" content="RGPV Syllabus and Timetable" />
<meta property="og:title" content="RGPV Syllabus and Timetable" />
<meta property="og:description" content="Download and view the latest RGPV syllabus and timetable in PDF." />

<!-- Other Tags -->
<link rel="prefetch" />
<meta name="audience" content="all" />
<meta name="rating" content="general" />
<meta name="generator" content="site" />
<meta name="google" content="translate" />
<meta name="theme-color" content="#4DBA87" />
<meta name="geo.placename" content="India" />
<meta name="revisit-after" content="1 days" />
<meta property="fb:admins" content="100012765211323" />
<meta name="apple-mobile-web-app-capable" content="no" />

<!-- Apple Touch Icon -->
<meta name="apple-mobile-web-app-title" content="www.rgpv-syllabus-timetable.in" />
<meta name="apple-mobile-web-app-status-bar-style" content="default" />
<link rel="apple-touch-icon" href="/img/icons/apple-touch-icon-152x152.png" />

<!-- Favicon and Icons -->
<link rel="mask-icon" href="/img/icons/safari-pinned-tab.svg" color="#4DBA87" />
<link rel="icon" type="image/png" sizes="32x32" href="/img/icons/favicon-32x32.png" />
<link rel="icon" type="image/png" sizes="16x16" href="/img/icons/favicon-16x16.png" />
<meta name="msapplication-TileImage" content="/img/icons/msapplication-icon-144x144.png" />

<!-- Search Engine Tags -->
<meta name="search engines" content="Aeiwi, Alexa, AllTheWeb, AltaVista, AOL Netfind, Anzwers, Canada, DirectHit, EuroSeek, Excite, Overture, Go, Google, HotBot, InfoMak, Kanoodle, Lycos, MasterSite, National Directory, Northern Light, SearchIt, SimpleSearch, WebsMostLinked, WebTop, What-U-Seek, AOL, Yahoo, WebCrawler, Infoseek, Excite, Magellan, LookSmart, CNET, Googlebot" />

<!-- Pingback and OpenID -->
<link rel="pingback" href="https://www.rgpv-syllabus-timetable.in/" />
<link rel="openid.delegate" href="https://www.rgpv-syllabus-timetable.in/" />

<!-- Content Type -->
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
<body><div style="display:flex;justify-content:flex-end;"><a href="#" target="_blank" download="" id="pdf-download-link"><button type="button" style="cursor:pointer;-webkit-appearance:button;color:#fff;background-color:#007bff;border-color:#007bff;display:inline-block;font-weight:400;text-align:center;white-space:nowrap;vertical-align:middle;-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;border:1px solid transparent;padding:0.375rem 0.75rem;font-size:1rem;line-height:1.5;border-radius:0.25rem;transition:color .15s ease-in-out,background-color .15s ease-in-out,border-color .15s ease-in-out,box-shadow .15s ease-in-out;text-transform:none;overflow:visible;margin:0;font-family:inherit;" download>Download PDF</button></a></div><script>const a=(window.location.pathname).split("/");const filename="" + a[a.length-1] + ".pdf";document.getElementById("pdf-download-link").href=filename;</script><h1 style="padding-top: 3pt;padding-left: 47pt;text-indent: 0pt;text-align: center;">SEMESTER VII</h1><h2 style="padding-top: 3pt;padding-left: 47pt;text-indent: 0pt;text-align: center;">BP701T.INSTRUMENTALMETHODSOFANALYSIS(Theory)</h2><h2 style="padding-top: 5pt;text-indent: 0pt;text-align: right;">45Hours</h2><h2 style="padding-top: 5pt;padding-left: 30pt;text-indent: 0pt;text-align: justify;">Scope: <span class="p">This subject deals with the application of instrumental methods in qualitative andquantitativeanalysisofdrugs.Thissubjectisdesignedtoimpartafundamentalknowledge on the    principles    and    instrumentation    of    spectroscopic    and chromatographictechnique.Thisalsoemphasizesontheoreticalandpracticalknowledgeonmod ernanalyticalinstruments that areusedfordrugtesting.</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-top: 10pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">Objectives:<span class="p">Upon completionofthecoursethestudentshallbe ableto</span></h2><ol id="l1"><li data-list-text="1."><p style="padding-top: 5pt;padding-left: 66pt;text-indent: -18pt;text-align: left;">Understandtheinteractionofmatterwithelectromagneticradiationsanditsapplications indruganalysis</p></li><li data-list-text="2."><p style="padding-top: 5pt;padding-left: 66pt;text-indent: -17pt;text-align: left;">Understandthechromatographicseparationandanalysis ofdrugs.</p></li><li data-list-text="3."><p style="padding-top: 5pt;padding-left: 65pt;text-indent: -17pt;text-align: left;">Performquantitative&amp;qualitativeanalysisofdrugsusingvariousanalyticalinstruments</p></li></ol><p style="padding-left: 66pt;text-indent: 0pt;text-align: left;">.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 47pt;text-indent: 0pt;text-align: center;">CourseContent:</h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 10pt;text-indent: 0pt;text-align: center;">UNIT–I                                             10Hours</h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 7pt;text-indent: 0pt;text-align: left;">UVVisiblespectroscopy</h2><p style="padding-top: 4pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">Electronictransitions,chromophores,auxochromes,spectralshifts,solventeffectonabsorptionspect ra,BeerandLambert’slaw,Derivationanddeviations.</p><p style="padding-top: 5pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">Instrumentation-Sourcesofradiation,wavelengthselectors,samplecells,detectors- Phototube,Photomultipliertube,Photovoltaiccell,SiliconPhotodiode.</p><p style="padding-top: 5pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">Applications-Spectrophotometrictitrations,Singlecomponentandmulticomponentanalysis</p><h2 style="padding-top: 7pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">Fluorimetry</h2><p style="padding-top: 4pt;padding-left: 7pt;text-indent: 0pt;text-align: justify;">Theory, Concepts of singlet, doublet and triplet electronic states, internal and externalconversions,factorsaffectingfluorescence,quenching,instrumentationandapplica tions</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 9pt;text-indent: 0pt;text-align: left;">UNIT–II                                            10Hours</h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 7pt;text-indent: 0pt;text-align: left;">IRspectroscopy</h2><p style="padding-top: 5pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">Introduction,fundamentalmodesofvibrationsinpolyatomicmolecules,samplehandling,factorsa ffectingvibrations</p><p style="padding-top: 6pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">Instrumentation-Sourcesofradiation,wavelengthselectors,detectors- Golaycell,Bolometer,Thermocouple,Thermister,Pyroelectricdetector andapplications</p><h2 style="padding-top: 6pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">FlamePhotometry-<span class="p">Principle,interferences,instrumentationandapplications</span></h2><h2 style="padding-top: 3pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">Atomicabsorptionspectroscopy<span class="p">- Principle,interferences,instrumentationandapplications</span></h2><h2 style="padding-top: 6pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">Nepheloturbidometry<span class="p">- Principle,instrumentationandapplications</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 7pt;text-indent: 0pt;text-align: left;">UNIT–III                                           10Hours</h2><h2 style="padding-top: 6pt;padding-left: 7pt;text-indent: 0pt;line-height: 19pt;text-align: left;">Introductiontochromatography Adsorptionandpartitioncolumnchromatography-</h2><p style="padding-left: 7pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Methodology,advantages,disadvantagesandapplications.</p><h2 style="padding-top: 6pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">Thinlayerchromatography- <span class="p">Introduction,Principle,Methodology,Rfvalues,advantages,disadvantages and applications.</span></h2><h2 style="padding-top: 6pt;padding-left: 49pt;text-indent: -42pt;text-align: left;">Paper chromatography-<span class="p">Introduction,  methodology, development techniques,advantages,disadvantages and applications</span></h2><h2 style="padding-top: 6pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">Electrophoresis<span class="p">– Introduction, factors affecting electrophoretic mobility, Techniquesofpaper,gel,capillaryelectrophoresis, applications</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 7pt;text-indent: 0pt;text-align: left;">UNIT–IV                                           08Hours</h2><h2 style="padding-top: 11pt;padding-left: 37pt;text-indent: -29pt;text-align: left;">Gas chromatography - <span class="p">Introduction, theory, instrumentation, derivatization,temperatureprogramming,advantages,disadvantagesandapplicatio</span></h2><p style="padding-left: 7pt;text-indent: 0pt;line-height: 14pt;text-align: left;">ns</p><h2 style="padding-top: 6pt;padding-left: 46pt;text-indent: -38pt;text-align: left;">High  performance  liquid  chromatography  (HPLC)-<span class="p">Introduction, theory,instrumentation,advantagesand applications.</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT–V                                            07Hours</h2><h2 style="padding-top: 10pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">Ionexchange    chromatography-<span class="p">Introduction,classification,    ionexchange resins,properties,mechanismofionexchangeprocess,factorsaffectingionexchange,metho dologyandapplications</span></h2><h2 style="padding-top: 6pt;padding-left: 7pt;text-indent: 0pt;line-height: 146%;text-align: left;">Gelchromatography-<span class="p">Introduction,theory,instrumentationandapplications </span>Affinitychromatography- <span class="p">Introduction,theory,instrumentationandapplications</span></h2><h2 style="padding-top: 3pt;padding-left: 47pt;text-indent: 0pt;text-align: center;">BP702T.INDUSTRIAL PHARMACYII(Theory)</h2><h2 style="padding-top: 6pt;text-indent: 0pt;text-align: right;">45Hours</h2><h2 style="padding-top: 4pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">Scope:<span class="p">Thiscourseisdesignedtoimpartfundamentalknowledgeonpharmaceuticalproductdeve lopment andtranslationfromlaboratoryto market</span></h2><h2 style="padding-top: 5pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">Objectives:<span class="p">Upon completionofthecourse,thestudentshallbeableto:</span></h2><ol id="l2"><li data-list-text="1."><p style="padding-top: 6pt;padding-left: 65pt;text-indent: -17pt;text-align: left;">Knowtheprocessof pilotplantandscaleupofpharmaceuticaldosageforms</p></li><li data-list-text="2."><p style="padding-top: 5pt;padding-left: 65pt;text-indent: -17pt;text-align: left;">Understand theprocess oftechnologytransferfrom lab scaleto commercial batch</p></li><li data-list-text="3."><p style="padding-top: 6pt;padding-left: 65pt;text-indent: -17pt;text-align: left;">KnowdifferentLawsandActsthatregulatepharmaceuticalindustry</p></li><li data-list-text="4."><p style="padding-top: 5pt;padding-left: 65pt;text-indent: -17pt;text-align: left;">Understandthe approvalprocessandregulatoryrequirementsfordrugproducts</p></li></ol><h2 style="padding-top: 7pt;padding-left: 47pt;text-indent: 0pt;text-align: center;">CourseContent:</h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-top: 10pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">UNIT-I                                     10Hours</h2><h2 style="padding-top: 4pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">Pilotplantscaleuptechniques:<span class="p">Generalconsiderations-including significanceofpersonnelrequirements,spacerequirements,rawmaterials,Pilotplantscaleupco nsiderations  for  solids,  liquid  orals,  semi  solids  and  relevant  documentation, SUPACguidelines,Introduction toplatformtechnology</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 30pt;text-indent: 0pt;text-align: left;">UNIT-II                                     10Hours</h2><h2 style="padding-top: 4pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">Technologydevelopmentandtransfer:<span class="p">WHOguidelinesforTechnologyTransfer(TT):Termi nology,Technologytransferprotocol,Qualityriskmanagement,TransferfromR&amp;Dtoproducti on(Process,packagingandcleaning),GranularityofTTProcess(API,excipients,finishedproduc ts,packagingmaterials)Documentation,Premisesandequipments,qualificationandvalidation, qualitycontrol,analyticalmethodtransfer,Approvedregulatorybodiesandagencies,Commerci alization-practicalaspectsandproblems(casestudies),TTagenciesinIndia- APCTD,NRDC,TIFAC,BCIL,TBSE/SIDBI; TT related  documentation-</span></h2><p style="padding-left: 145pt;text-indent: 0pt;text-align: left;">confidentialityagreement,licensing,MoUs,legalissues</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 30pt;text-indent: 0pt;text-align: left;">UNIT-III                                    10Hours</h2><h2 style="padding-top: 4pt;padding-left: 30pt;text-indent: 0pt;text-align: justify;">Regulatory  affairs:  <span class="p">Introduction,  Historical  overview  of  Regulatory  Affairs, Regulatoryauthorities,  Role  of  Regulatory  affairs  department,  Responsibility  of Regulatory AffairsProfessionals</span></h2><h2 style="padding-top: 6pt;padding-left: 30pt;text-indent: 0pt;text-align: justify;">Regulatory requirements for drug approval: <span class="p">Drug Development Teams, Non- ClinicalDrugDevelopment,Pharmacology,DrugMetabolismandToxicology,Generalconside rations of Investigational New Drug (IND) Application, Investigator’s Brochure(IB) and New Drug Application (NDA), Clinical research / BE studies, Clinical ResearchProtocols, Biostatistics  in  Pharmaceutical  Product  Development,  Data  Presentation forFDASubmissions,Management ofClinicalStudies.</span></h2><h2 style="padding-top: 3pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">UNIT-IV                                    08Hours</h2><h2 style="padding-top: 5pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">Qualitymanagementsystems:<span class="p">Quality management&amp;Certifications:ConceptofQuality,TotalQualityManagement,QualitybyDesig n(QbD),SixSigmaconcept,Outof        Specifications(OOS),        Change control,IntroductiontoISO9000seriesofqualitysystemsstandards,ISO14000, NABL,GLP</span></h2><h2 style="padding-top: 6pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">UNIT-V                                07Hours</h2><h2 style="padding-top: 4pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">IndianRegulatoryRequirements:<span class="p">CentralDrugStandardControlOrganization(CDSCO) and  State  Licensing  Authority:  Organization,  Responsibilities,  Certificate ofPharmaceutical Product (COPP), Regulatory requirements and approval procedures forNewDrugs.</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 30pt;text-indent: 0pt;text-align: left;">Recommended Books:(LatestEditions)</h2><ol id="l3"><li data-list-text="1."><p style="padding-top: 5pt;padding-left: 30pt;text-indent: -18pt;text-align: left;">Regulatory Affairs from Wikipedia, the free encyclopedia modified on 7<span class="s1">th</span> April availableathttp,//en.wikipedia.org/wiki/Regulatory_ Affairs.</p></li><li data-list-text="2."><p style="padding-top: 5pt;padding-left: 30pt;text-indent: -18pt;text-align: left;">InternationalRegulatoryAffairsUpdates,2005.availableathttp</p><p style="padding-left: 30pt;text-indent: 0pt;text-align: left;"><a href="http://www.iraup.com/about.php" class="a" target="_blank">://</a><a href="http://www.iraup.com/about.php" target="_blank">www.iraup.com/about.php</a></p></li><li data-list-text="3."><p style="padding-top: 5pt;padding-left: 30pt;text-indent: -18pt;text-align: left;">Douglas J Pisano and David S. Mantus. Text book of FDA Regulatory Affairs A GuideforPrescriptionDrugs,MedicalDevices,andBiologics’SecondEdition.</p></li><li data-list-text="4."><p style="padding-top: 5pt;padding-left: 30pt;text-indent: -18pt;text-align: left;"><a href="http://www.cgmp.com/" class="a" target="_blank">RegulatoryAffairs broughtbylearningplus,inc.availableathttp.//</a>www.cgmp.com/ ra.htm.</p><h2 style="padding-top: 3pt;padding-left: 47pt;text-indent: 0pt;text-align: center;">BP703T.PHARMACYPRACTICE(Theory)</h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="text-indent: 0pt;text-align: right;">45Hours</h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-top: 4pt;padding-left: 30pt;text-indent: 0pt;line-height: 114%;text-align: left;">Scope: <span class="p">In the changing scenario of pharmacy practice in India, for successful practice ofHospital Pharmacy, the students are required to learn various skills like drug distribution,druginformation,andtherapeuticdrugmonitoringforimprovedpatientcare.Incom munity pharmacy,studentswillbelearningvariousskillssuchasdispensingofdrugs,respondingtominor ailmentsbyprovidingsuitablesafemedication,patientcounsellingfor improvedpatient carein thecommunityset up.</span></h2><h2 style="padding-top: 9pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">Objectives:<span class="p">Upon completionofthecourse,thestudentshallbeableto</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l4"><li data-list-text="1."><p style="padding-left: 65pt;text-indent: -17pt;text-align: left;">knowvarious drugdistributionmethodsinahospital</p></li><li data-list-text="2."><p style="padding-top: 2pt;padding-left: 65pt;text-indent: -17pt;text-align: left;">appreciate the pharmacystoresmanagementand inventorycontrol</p></li><li data-list-text="3."><p style="padding-top: 2pt;padding-left: 65pt;text-indent: -17pt;text-align: left;">monitordrugtherapyofpatientthroughmedicationchartreviewandclinicalreview</p></li><li data-list-text="4."><p style="padding-top: 2pt;padding-left: 65pt;text-indent: -17pt;text-align: left;">obtainmedicationhistoryinterviewandcounsel thepatients</p></li><li data-list-text="5."><p style="padding-top: 2pt;padding-left: 65pt;text-indent: -17pt;text-align: left;">identifydrugrelatedproblems</p></li><li data-list-text="6."><p style="padding-top: 2pt;padding-left: 65pt;text-indent: -17pt;text-align: left;">detectandassessadversedrugreactions</p></li><li data-list-text="7."><p style="padding-top: 1pt;padding-left: 66pt;text-indent: -18pt;line-height: 114%;text-align: left;">interpretselectedlaboratoryresults(asmonitoringparametersintherapeutics)ofspecifi cdiseasestates</p></li><li data-list-text="8."><p style="padding-left: 65pt;text-indent: -17pt;line-height: 14pt;text-align: left;">knowpharmaceuticalcareservices</p></li><li data-list-text="9."><p style="padding-top: 2pt;padding-left: 65pt;text-indent: -17pt;text-align: left;">dopatientcounselingincommunitypharmacy;</p></li><li data-list-text="10."><p style="padding-top: 2pt;padding-left: 65pt;text-indent: -17pt;text-align: left;">appreciatetheconceptofRationaldrugtherapy.</p></li></ol></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 30pt;text-indent: 0pt;text-align: left;">UnitI:                                      10Hours</h2><ol id="l5"><li data-list-text="a)"><h2 style="padding-top: 1pt;padding-left: 43pt;text-indent: -13pt;text-align: left;">Hospitalandit’sorganization</h2><p style="padding-top: 1pt;padding-left: 43pt;text-indent: 0pt;line-height: 113%;text-align: left;">Definition,Classificationofhospital- Primary,SecondaryandTertiaryhospitals,Classification based on clinical and  non- clinical   basis,   Organization   Structure   of   aHospital,andMedicalstaffs involvedinthehospitalandtheirfunctions.</p></li><li data-list-text="b)"><h2 style="padding-top: 11pt;padding-left: 43pt;text-indent: -13pt;text-align: left;">Hospitalpharmacyanditsorganization</h2><p style="padding-top: 10pt;padding-left: 44pt;text-indent: 0pt;line-height: 114%;text-align: left;">Definition, functions of hospital pharmacy, Organization structure, Location, Layoutandstaffrequirements,andResponsibilitiesandfunctionsofhospitalpharmacists.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="c)"><h2 style="padding-left: 42pt;text-indent: -12pt;text-align: left;">Adversedrugreaction</h2><p style="padding-top: 1pt;padding-left: 44pt;text-indent: 0pt;line-height: 115%;text-align: left;">Classifications-Excessivepharmacologicaleffects,secondarypharmacologicaleffects, idiosyncrasy,  allergic  drug  reactions,  genetically  determined  toxicity, toxicityfollowingsuddenwithdrawalofdrugs,Druginteraction- beneficialinteractions,adverseinteractions,andpharmacokineticdruginteractions,Methods fordetecting</p><p style="padding-top: 3pt;padding-left: 44pt;text-indent: 0pt;line-height: 112%;text-align: left;">drug  interactions,  spontaneous  case  reports and  record  linkage  studies,  and Adversedrugreactionreportingand management.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="d)"><h2 style="padding-left: 43pt;text-indent: -13pt;text-align: left;">Community Pharmacy</h2></li></ol><p style="padding-top: 1pt;padding-left: 44pt;text-indent: 0pt;line-height: 113%;text-align: left;">Organization and structure of retail and wholesale drug store, types and design, Legalrequirementsforestablishmentandmaintenanceofadrugstore,Dispensingofproprieta ryproducts, maintenanceof records ofretailandwholesaledrugstore.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 30pt;text-indent: 0pt;text-align: left;">UnitII:                                      10Hours</h2><ol id="l6"><li data-list-text="a)"><h2 style="padding-top: 2pt;padding-left: 44pt;text-indent: -14pt;line-height: 112%;text-align: left;">Drugdistribution systemin ahospital <span class="p">Dispensingofdrugstoinpatients,typesofdrugdistributionsystems,chargingpolicyandlabell ing,Dispensingofdrugstoambulatorypatients,andDispensingofcontrolleddrugs.</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="b)"><h2 style="padding-left: 44pt;text-indent: -14pt;text-align: justify;">Hospitalformulary</h2><p style="padding-top: 1pt;padding-left: 44pt;text-indent: 0pt;line-height: 113%;text-align: justify;">Definition, contents of hospital formulary, Differentiation of hospital formulary andDrug list, preparation and revision, and addition and deletion of drug from hospitalformulary.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="c)"><h2 style="padding-left: 43pt;text-indent: -17pt;line-height: 111%;text-align: left;">	Therapeuticdrugmonitoring <span class="p">NeedforTherapeuticDrugMonitoring,FactorstobeconsideredduringtheTherapeuticDrug Monitoring,andIndianscenarioforTherapeuticDrugMonitoring.</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="d)"><h2 style="padding-left: 44pt;text-indent: -14pt;text-align: left;">Medicationadherence</h2><p style="padding-top: 1pt;padding-left: 44pt;text-indent: 0pt;line-height: 112%;text-align: left;">Causesofmedicationnon- adherence,pharmacistroleinthemedicationadherence,andmonitoringofpatientmedication adherence.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="e)"><h2 style="padding-left: 47pt;text-indent: -17pt;text-align: justify;">Patientmedicationhistoryinterview</h2><p style="padding-top: 1pt;padding-left: 44pt;text-indent: 0pt;text-align: left;">Needfor the patient medicationhistoryinterview,medicationinterviewforms.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="f)"><h2 style="padding-left: 48pt;text-indent: -18pt;text-align: left;">Communitypharmacymanagement</h2></li></ol><p style="padding-top: 1pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">Financial,materials,staff,andinfrastructurerequirements.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 30pt;text-indent: 0pt;text-align: left;">UnitIII:                                     10Hours</h2><ol id="l7"><li data-list-text="a)"><h2 style="padding-top: 2pt;padding-left: 43pt;text-indent: -13pt;line-height: 112%;text-align: left;">	Pharmacyandtherapeuticcommittee <span class="p">Organization,functions,Policiesofthepharmacyandtherapeuticcommitteeinincludingdrug sintoformulary,inpatientandoutpatientprescription,automaticstoporder,andemergencydr uglist preparation</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 43pt;text-indent: 0pt;text-align: left;">Drug<b>informationservice:</b></p><p style="padding-top: 3pt;padding-left: 44pt;text-indent: 0pt;line-height: 112%;text-align: left;">DrugandPoisoninformationcentre,Sourcesofdruginformation,Computerisedservices,and storageandretrievalofinformation.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 43pt;text-indent: -13pt;line-height: 112%;text-align: left;">Patientcounseling <span class="p">Definitionofpatientcounseling;stepsinvolvedinpatientcounseling,andSpecialcasesthatreq uirethepharmacist</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="b)"><h2 style="padding-left: 43pt;text-indent: -13pt;line-height: 112%;text-align: left;">	Educationandtrainingprogramin thehospital <span class="p">Roleofpharmacistintheeducationandtrainingprogram,Internalandexternaltraining program,  Services  to  the  nursing  homes/clinics,  Code  of  ethics  for communitypharmacy,andRoleofpharmacistintheinterdepartmentalcommunicationandco mmunityhealth education.</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="c)"><h2 style="padding-left: 43pt;text-indent: -13pt;line-height: 113%;text-align: left;">	Prescribedmedicationorderandcommunicationskills <span class="p">Prescribedmedicationorder- interpretationandlegalrequirements,andCommunicationskills- communicationwithprescribersandpatients.</span></h2></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 30pt;text-indent: 0pt;text-align: justify;">UnitIV                                          8Hours</h2><ol id="l8"><li data-list-text="a)"><h2 style="padding-top: 1pt;padding-left: 17pt;text-indent: -17pt;text-align: center;">Budgetpreparationandimplementation</h2><p style="padding-top: 1pt;padding-left: 47pt;text-indent: 0pt;text-align: center;">Budgetpreparationandimplementation</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="b)"><h2 style="padding-left: 44pt;text-indent: -14pt;line-height: 112%;text-align: left;">ClinicalPharmacy <span class="p">IntroductiontoClinicalPharmacy,Conceptofclinicalpharmacy,functionsandresponsibiliti esofclinicalpharmacist,Drug  therapy  monitoring-medicationchartreview,  clinical review, pharmacist intervention, Ward round participation, Medicationhistoryand Pharmaceutical care.</span></h2><p style="padding-top: 1pt;padding-left: 43pt;text-indent: 0pt;text-align: left;">DosingpatternanddrugtherapybasedonPharmacokinetic &amp;diseasepattern.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="c)"><h2 style="padding-left: 43pt;text-indent: -13pt;line-height: 110%;text-align: left;">	Overthecounter(OTC)sales <span class="p">Introductionandsaleofoverthecounter,andRationaluseofcommonoverthecountermedicati ons.</span></h2></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 30pt;text-indent: 0pt;text-align: justify;">UnitV                                           7Hours</h2><ol id="l9"><li data-list-text="a)"><h2 style="padding-top: 2pt;padding-left: 44pt;text-indent: -14pt;text-align: justify;">Drugstore managementandinventorycontrol</h2><p style="padding-top: 1pt;padding-left: 44pt;text-indent: 0pt;line-height: 114%;text-align: justify;">Organisation of drug store, types of materials stocked and storage conditions, Purchaseand   inventory  control:principles,   purchase   procedure,   purchase order,procurementand stocking, Economic order quantity, Reorder quantity level, and Methods used fortheanalysisofthedrugexpenditure</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="b)"><h2 style="padding-left: 44pt;text-indent: -14pt;text-align: justify;">Investigationaluseofdrugs</h2><p style="padding-top: 3pt;padding-left: 44pt;text-indent: 0pt;line-height: 112%;text-align: left;">Description,principlesinvolved,classification,control,identification,roleofhospitalpharmacist, advisorycommittee.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="c)"><h2 style="padding-left: 44pt;text-indent: -14pt;text-align: left;">InterpretationofClinicalLaboratoryTests</h2><p style="padding-top: 1pt;padding-left: 29pt;text-indent: 0pt;text-align: left;">Bloodchemistry,hematology,andurinalysis</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 30pt;text-indent: 0pt;text-align: left;">Recommended Books(LatestEdition):</h2><ol id="l10"><li data-list-text="1."><p style="padding-top: 10pt;padding-left: 66pt;text-indent: -18pt;line-height: 114%;text-align: left;">MerchantS.H.and Dr.J.S.Quadry. <i>Atextbookof hospitalpharmacy</i>,4thed.Ahmadabad:B.S.ShahPrakakshan; 2001.</p></li><li data-list-text="2."><p style="padding-left: 66pt;text-indent: -18pt;line-height: 112%;text-align: left;">ParthasarathiG,KarinNyfort-Hansen,Milap CNahata.<i>AtextbookofClinicalPharmacy Practice- essential concepts and skills, </i>1<span class="s1">st</span> ed. Chennai: OrientLongmanPrivateLimited; 2004.</p></li><li data-list-text="3."><p style="padding-left: 65pt;text-indent: -17pt;text-align: left;">WilliamE.Hassan.<i>Hospitalpharmacy</i>,5thed.Philadelphia:Lea&amp;Febiger;1986.</p></li><li data-list-text="4."><p style="padding-top: 2pt;padding-left: 65pt;text-indent: -17pt;text-align: left;">TipnisBajaj.<i>HospitalPharmacy</i>,1<span class="s1">st</span>ed.Maharashtra:CareerPublications;2008.</p></li><li data-list-text="5."><p style="padding-top: 1pt;padding-left: 66pt;text-indent: -18pt;line-height: 114%;text-align: left;">Scott LT. <i>Basic skills in interpreting laboratory data</i>, 4thed<i>. </i>American Society ofHealthSystemPharmacistsInc; 2009.</p></li><li data-list-text="6."><p style="padding-left: 66pt;text-indent: -18pt;line-height: 114%;text-align: left;">ParmarN.S.<i>Health EducationandCommunityPharmacy,</i>18thed.India:CBSPublishers&amp;Distributers</p></li></ol></li></ol><p style="padding-left: 66pt;text-indent: 0pt;line-height: 14pt;text-align: left;">; 2008.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 48pt;text-indent: 0pt;text-align: left;">Journals:</h2><ol id="l11"><li data-list-text="1."><p style="padding-top: 10pt;padding-left: 65pt;text-indent: -17pt;text-align: left;">Therapeuticdrugmonitoring.ISSN:0163-4356</p></li><li data-list-text="2."><p style="padding-top: 2pt;padding-left: 65pt;text-indent: -17pt;text-align: left;">Journalofpharmacypractice.ISSN:0974-8326</p></li><li data-list-text="3."><p style="padding-top: 2pt;padding-left: 65pt;text-indent: -17pt;text-align: left;">Americanjournalofhealthsystempharmacy.ISSN:1535-2900(online)</p></li><li data-list-text="4."><p style="padding-top: 2pt;padding-left: 65pt;text-indent: -17pt;text-align: left;">Pharmacytimes(Monthlymagazine)</p></li></ol><h2 style="padding-top: 3pt;padding-left: 100pt;text-indent: 0pt;text-align: left;">BP704T:NOVEL DRUGDELIVERYSYSTEMS(Theory)</h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-top: 10pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">Scope:<span class="p">Thissubjectisdesignedtoimpartbasicknowledgeonthe areaofnoveldrugdeliverysystems.</span></h2><h2 style="padding-top: 6pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">Objectives:<span class="p">Upon completionofthecoursestudentshallbeable</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-top: 8pt;padding-left: 24pt;text-indent: 0pt;text-align: left;">45Hours</h2><ol id="l12"><li data-list-text="1."><p style="padding-top: 5pt;padding-left: 47pt;text-indent: -17pt;text-align: left;">To understand various approachesfordevelopmentofnovel drugdeliverysystems.</p></li><li data-list-text="2."><p style="padding-left: 48pt;text-indent: -18pt;text-align: left;">To understand the criteria for selection of drugs and polymers for the development ofNovel drugdeliverysystems, theirformulation and evaluation</p></li></ol><h2 style="padding-top: 7pt;padding-left: 208pt;text-indent: 0pt;text-align: left;">Coursecontent:</h2><h2 style="padding-top: 5pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">Unit-I                                      10Hours</h2><h2 style="padding-top: 5pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">Controlled  drug  delivery  systems<span class="p">:  Introduction,  terminology/definitions  and rationale,advantages, disadvantages, selection of drug candidates.Approaches to design controlledreleaseformulationsbasedondiffusion,dissolutionandionexchangeprinciples.Phys icochemicalandbiologicalpropertiesofdrugsrelevanttocontrolledreleaseformulations</span></h2><h2 style="padding-top: 6pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">Polymers:<span class="p">Introduction,classification,properties,advantagesandapplicationofpolymersin formulationofcontrolledrelease drugdeliverysystems.</span></h2><h2 style="padding-top: 7pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">Unit-II                                      10Hours</h2><h2 style="padding-top: 4pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">Microencapsulation: <span class="p">Definition, advantages and disadvantages, microspheres</span></h2><p style="padding-left: 30pt;text-indent: 0pt;text-align: left;">/microcapsules,microparticles,methodsofmicroencapsulation,applications</p><h2 style="padding-top: 5pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">MucosalDrugDeliverysystem:<span class="p">Introduction,Principlesofbioadhesion/mucoadhesion, concepts, advantages and disadvantages, transmucosal permeability andformulation considerations ofbuccal deliverysystems</span></h2><h2 style="padding-top: 6pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">ImplantableDrugDeliverySystems:<span class="p">Introduction,advantagesanddisadvantages,conceptofi mplantsand osmoticpump</span></h2><h2 style="padding-top: 7pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">Unit-III                                     10Hours</h2><h2 style="padding-top: 4pt;padding-left: 30pt;text-indent: 0pt;text-align: justify;">Transdermal  Drug  Delivery  Systems:<span class="p">Introduction,  Permeation  through  skin, factorsaffecting      permeation,permeationenhancers,basic      componentsof TDDS,formulationapproaches</span></h2><h2 style="padding-top: 5pt;padding-left: 30pt;text-indent: 0pt;text-align: justify;">Gastroretentivedrugdeliverysystems:<span class="p">Introduction,advantages,disadvantages,approaches for   GRDDS   –   Floating,   high   density   systems,   inflatable   and gastroadhesivesystemsandtheirapplications</span></h2><h2 style="padding-top: 6pt;padding-left: 30pt;text-indent: 0pt;text-align: justify;">Nasopulmonary drug delivery system: <span class="p">Introduction to Nasal and Pulmonary routes ofdrug            delivery,FormulationofInhalers(dry            powder andmetereddose),nasalsprays,nebulizers</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 30pt;text-indent: 0pt;text-align: left;">Unit-IV                                     08Hours</h2><h2 style="padding-top: 3pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">TargeteddrugDelivery:<span class="p">Conceptsandapproachesadvantagesanddisadvantages,introduction toliposomes,niosomes,nanoparticles,monoclonalantibodiesandtheirapplications</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 30pt;text-indent: 0pt;text-align: left;">Unit-V                                     07Hours</h2><h2 style="padding-top: 4pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">OcularDrugDeliverySystems:<span class="p">Introduction,intraocularbarriersandmethodstoovercome – Preliminarystudy,ocularformulationsandocuserts</span></h2><h2 style="padding-top: 5pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">IntrauterineDrugDeliverySystems:<span class="p">Introduction,advantagesanddisadvantages,developme ntofintrauterinedevices (IUDs) andapplications</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-top: 11pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">Recommended Books:(LatestEditions)</h2><ol id="l13"><li data-list-text="1."><p style="padding-top: 5pt;padding-left: 30pt;text-indent: -18pt;text-align: left;">	YW.Chien,NovelDrugDeliverySystems,2<span class="s1">nd</span>edition,revisedandexpanded,MarcelDe kker,Inc., NewYork,1992.</p></li><li data-list-text="2."><p style="padding-top: 5pt;padding-left: 30pt;text-indent: -18pt;text-align: left;">	Robinson,J.R.,LeeV.H.L,ControlledDrugDeliverySystems,MarcelDekker,Inc.,Ne wYork,1992.</p></li><li data-list-text="3."><p style="padding-top: 6pt;padding-left: 30pt;text-indent: -18pt;text-align: left;">	EncyclopediaofControlledDelivery.EdithMathiowitz,PublishedbyWileyInterscien ce Publication,JohnWileyandSons,Inc,New York.Chichester/Weinheim</p></li><li data-list-text="4."><p style="padding-top: 6pt;padding-left: 30pt;text-indent: -18pt;text-align: left;">	N.K.Jain,ControlledandNovelDrugDelivery,CBSPublishers&amp;Distributors,NewDel hi,First edition1997(reprintin2001).</p></li><li data-list-text="5."><p style="padding-top: 5pt;padding-left: 30pt;text-indent: -18pt;text-align: left;">	S.P.VyasandR.K.Khar,ControlledDrugDelivery- conceptsandadvances,VallabhPrakashan,NewDelhi,First edition2002.</p></li></ol><h2 style="padding-top: 6pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">Journals</h2><ol id="l14"><li data-list-text="1."><p style="padding-top: 5pt;padding-left: 66pt;text-indent: -54pt;text-align: left;">IndianJournalofPharmaceuticalSciences(IPA)</p></li><li data-list-text="2."><p style="padding-top: 5pt;padding-left: 66pt;text-indent: -54pt;text-align: left;">IndianDrugs (IDMA)</p></li><li data-list-text="3."><p style="padding-top: 6pt;padding-left: 65pt;text-indent: -53pt;text-align: left;">JournalofControlledRelease(ElsevierSciences)</p></li><li data-list-text="4."><p style="padding-top: 5pt;padding-left: 65pt;text-indent: -53pt;text-align: left;">DrugDevelopment andIndustrial Pharmacy(Marcel&amp;Decker)</p></li><li data-list-text="5."><p style="padding-top: 6pt;padding-left: 66pt;text-indent: -54pt;text-align: left;">InternationalJournalofPharmaceutics(ElsevierSciences)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-top: 4pt;padding-left: 47pt;text-indent: 0pt;text-align: center;">BP705P.INSTRUMENTALMETHODSOFANALYSIS(Practical)</h2><h2 style="padding-top: 5pt;padding-left: 388pt;text-indent: 0pt;text-align: left;">4Hours/Week</h2><ol id="l15"><li data-list-text="2"><p style="padding-top: 5pt;padding-left: 58pt;text-indent: -31pt;line-height: 114%;text-align: left;">Determinationofabsorptionmaximaandeffectofsolventsonabsorptionmaximaofor ganiccompounds</p></li><li data-list-text="3"><p style="padding-left: 58pt;text-indent: -31pt;line-height: 14pt;text-align: left;">Estimation ofdextrosebycolorimetry</p></li><li data-list-text="4"><p style="padding-top: 2pt;padding-left: 58pt;text-indent: -31pt;text-align: left;">Estimation ofsulfanilamide bycolorimetry</p></li><li data-list-text="5"><p style="padding-top: 2pt;padding-left: 58pt;text-indent: -31pt;text-align: left;">SimultaneousestimationofibuprofenandparacetamolbyUVspectroscopy</p></li><li data-list-text="6"><p style="padding-top: 2pt;padding-left: 58pt;text-indent: -31pt;text-align: left;">AssayofparacetamolbyUV-Spectrophotometry</p></li><li data-list-text="7"><p style="padding-top: 2pt;padding-left: 58pt;text-indent: -31pt;text-align: left;">Estimation of quinine sulfate byfluorimetry</p></li><li data-list-text="8"><p style="padding-top: 2pt;padding-left: 58pt;text-indent: -31pt;text-align: left;">Studyof quenchingof fluorescence</p></li><li data-list-text="9"><p style="padding-top: 2pt;padding-left: 58pt;text-indent: -31pt;text-align: left;">Determinationof sodiumbyflame photometry</p></li><li data-list-text="10"><p style="padding-top: 2pt;padding-left: 58pt;text-indent: -31pt;text-align: left;">Determination ofpotassiumbyflame photometry</p></li><li data-list-text="11"><p style="padding-top: 2pt;padding-left: 58pt;text-indent: -34pt;text-align: left;">Determinationofchloridesandsulphatesbynepheloturbidometry</p></li><li data-list-text="12"><p style="padding-top: 2pt;padding-left: 58pt;text-indent: -34pt;text-align: left;">Separationof amino acidsbypaperchromatography</p></li><li data-list-text="13"><p style="padding-top: 2pt;padding-left: 58pt;text-indent: -34pt;text-align: left;">Separation of sugarsbythin layerchromatography</p></li><li data-list-text="14"><p style="padding-top: 2pt;padding-left: 58pt;text-indent: -34pt;text-align: left;">Separation of plantpigmentsbycolumnchromatography</p></li><li data-list-text="15"><p style="padding-top: 2pt;padding-left: 58pt;text-indent: -34pt;text-align: left;">DemonstrationexperimentonHPLC</p></li><li data-list-text="16"><p style="padding-top: 2pt;padding-left: 58pt;text-indent: -34pt;text-align: left;">DemonstrationexperimentonGasChromatography</p></li></ol></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 30pt;text-indent: 0pt;text-align: left;">Recommended Books(LatestEditions)</h2><ol id="l16"><li data-list-text="1."><p style="padding-top: 4pt;padding-left: 30pt;text-indent: -18pt;text-align: left;">InstrumentalMethodsofChemicalAnalysisbyB.KSharma</p></li><li data-list-text="2."><p style="padding-top: 6pt;padding-left: 29pt;text-indent: -17pt;text-align: left;">Organic spectroscopybyY.RSharma</p></li><li data-list-text="3."><p style="padding-top: 5pt;padding-left: 29pt;text-indent: -17pt;text-align: left;">TextbookofPharmaceutical AnalysisbyKennethA.Connors</p></li><li data-list-text="4."><p style="padding-top: 6pt;padding-left: 29pt;text-indent: -17pt;text-align: left;">Vogel’sTextbookofQuantitativeChemicalAnalysisbyA.I. Vogel</p></li><li data-list-text="5."><p style="padding-top: 5pt;padding-left: 29pt;text-indent: -17pt;text-align: left;">Practical PharmaceuticalChemistrybyA.H.Beckett andJ.B. Stenlake</p></li><li data-list-text="6."><p style="padding-top: 6pt;padding-left: 29pt;text-indent: -17pt;text-align: left;">Organic ChemistrybyI.L.Finar</p></li><li data-list-text="7."><p style="padding-top: 5pt;padding-left: 29pt;text-indent: -17pt;text-align: left;">Organic spectroscopybyWilliamKemp</p></li><li data-list-text="8."><p style="padding-top: 6pt;padding-left: 29pt;text-indent: -17pt;text-align: left;">QuantitativeAnalysisofDrugsbyD.C.Garrett</p></li><li data-list-text="9."><p style="padding-top: 5pt;padding-left: 29pt;text-indent: -17pt;text-align: left;">Quantitative AnalysisofDrugsinPharmaceuticalFormulationsbyP.D.Sethi</p></li><li data-list-text="10."><p style="padding-top: 6pt;padding-left: 29pt;text-indent: -17pt;text-align: left;">Spectrophotometric identificationof OrganicCompoundsbySilverstein</p></li></ol></body></html>
